Schindler T. Will the Food and Drug Administration’s New Standard of Requiring Only One Trial for a New Drug Application/Biologic License Application Have Repercussions for Medical Communicators?. AMWA [Internet]. 2026 Jun. 16 [cited 2026 Jun. 18];41(2). Available from: https://www.amwajournal.org/index.php/amwa/article/view/569